The previous high was 6.8 percent in 2008. The study surveys list prices for the 130 top-selling drugs.
Blood-pressure medicine Benicar topped the list, with its price soaring 29.3 percent. Leukemia therapy drug Gleevec registered a 20.9 percent increase, and attention-deficit-disorder drug Concerta 19.7 percent.
No comments:
Post a Comment